The first commercially available HMG-CoA reductase inhibitors in the US. were lovastatin and pravastatin. These two agents have generally simi1ar efficacy' Three published comparative trials indicate that when pravastatin andlovastatin are used at equal doses in patients with primary hypercholesterolemia, they achieve similar LDL-cholesterol reductions.s,1O More recently, simvastatin, fluvastatin, and atorvastatin have become available commercially These drugs differ from lovastatin and pravastatin in their LDL-cholesterollowering efficacy 11 
